Illumina Investor

Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.

Invests into

Technology: Neurological Disorders
Industry: Biotechnology, Genetics, Health Care, Medical
Headquarters: San Diego, California, United States
Founded Date: 1998-01-01
Employees Number: 5001-10000
Funding Status: IPO
Investor Type: Accelerator
Investment Stage: Early Stage Venture, Late Stage Venture
Number Of Exits: 6
Acquisitions Number: 6
Investors Number: 9
Total Funding: 28000000
Estimated Revenue: $500M to $1B
Last Funding Date: 2000
Last Funding Type: Venture - Series Unknown

Visit Website
Register and Claim Ownership